Arrowhead Pharmaceuticals, Inc.
ARWR· Nasdaq
Arrowhead Pharmaceuticals, Inc.
- Last sale
- Oct 1, 2026 · -1.04%
- Market cap
- $9.15B
- 141.25M shares
- Filings
- 1,010
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-09-30 | $829,448,000 | reported | |
| FY 2024 | 2024-09-30 | $3,551,000 | reported | |
| FY 2023 | 2023-09-30 | $240,735,000 | reported | |
| FY 2022 | 2022-09-30 | $243,231,000 | reported | |
| FY 2021 | 2021-09-30 | $138,287,000 | reported | |
| FY 2020 | 2020-09-30 | $87,992,066 | reported | |
| FY 2019 | 2019-09-30 | $168,795,577 | reported | |
| FY 2018 | 2018-09-30 | $16,142,321 | reported | |
| FY 2017 | 2017-09-30 | $31,407,709 | reported | |
| FY 2016 | 2016-09-30 | $158,333 | reported | |
| FY 2015 | 2015-09-30 | $382,000 | reported | |
| FY 2014 | 2014-09-30 | $175,000 | reported |
Arrowhead Pharmaceuticals, Inc. · CIK 879407 · Engraved from SEC EDGAR
